The present invention relates to pharmaceutical compositions having antiviral activity against Coronavirus, and more particularly against those viruses responsible for Severe Acute Respiratory Syndrome (SARS). In a preferred embodiment it comprises a total standardized extract of a Scutellariae spp.

 
Web www.patentalert.com

< METHODS AND MATERIALS FOR INCREASING THE ADHESION OF ELUTION CONTROL MATRICES TO SUBSTRATES

> Nanoparticulate megestrol formulations

~ 00411